Someone Else Sets the Price

The bulletin landed on a Tuesday morning in January.

Neil Barrett was at his desk before seven, coffee going cold, reading the overnight numbers. He liked those quiet hours. Two weeks earlier, the company had thrown its best Christmas party in years. They had earned it. After a brutal first year, profit was back to the level he had promised his investors. The plan was working again.

The alert was one line on a screen. A price update for their most important drug category.

The price had been cut by ninety percent.

Not their price. They never had a price. In this business, an insurance program decides what you get paid. Not you. Not the market. The rates come off a published list, and someone far away had just rewritten the list. No warning. No phone call. No meeting where Neil could stand up and make his case.

He did the math in his head, then on paper, then in the model, hunting for the mistake. There was no mistake. About two million dollars of yearly profit was gone. Same patients. Same nurses. Same medicine, mixed the same way, shipped the same night. All of it now paid at a tenth of Monday’s rate.

The company owed the bank twelve million dollars.

One number on one screen had repriced everything Neil had built, and the people who typed it did not know his name.

The Dream

Neil Barrett is a Navy veteran. He came out of the service with no money, no network, and no plan except work. He worked three months for free to break into consulting. Then ten dollars an hour, with a wife and two kids, finishing his degree at night. He does not tell that part as a sad story. He tells it as training.

It worked. Within a few years he was running a sixty-person team, selling to some of the biggest tech firms in the country. Then came a top-ten business school and an MBA. By his mid-thirties he had done everything in business except own the business.

The plan was a search fund. In plain words: investors put up money to pay you while you hunt for one good company, then fund the purchase, and in return they own most of it while your own house stays off the table.

Why that model? Neil had been married fourteen years. Three kids. His wife had one red line: no personal guarantee. Never bet the house. He agreed, he says with half a smile, because he wanted to stay married. Remember her rule. It is the only wall in this story that holds.

He did not search alone. A classmate from his program, Chris, was strong in finance where Neil was not. Neil took sales and growth. Chris took the books. Twenty-two investors backed them, and half were former searchers themselves. This was as far from a napkin deal as this world gets.

The search itself ran like a sales machine. Eight interns worked the phones in ten-week shifts. Five or six owner calls got booked every day. The fund was raised in about four months. The target turned up within two more. The deal closed six months after that. Start to keys in hand: under a year. That is fast. Very fast.

He moved his family across the country for it.

The Deal

The company was a home-infusion pharmacy in Georgia. Here is what that means. Some patients need IV drugs at home. Antibiotics for weeks. Special therapies for years. A pharmacy like this one mixes those drugs in a sterile clean room and ships them overnight, so the medicine is at the patient’s door by morning. Real medicine. Real skill. About twenty million dollars a year in revenue.

The stated profit was a little over three million dollars a year. The price was six times that profit. The money stacked like this: about twelve million dollars of bank debt, a note owed to the seller on top, and the investors’ equity underneath.

Ask why so much debt and you get the honest answer Neil gave me. They had asked the bank one question: what is the most you will lend us? He said it flat, like a man reading a weather report: the debt maximized the chance of great returns, and it maximized the chance of default. They knew. It was a choice.

The debt cost about $200,000 a month. Payroll ran about $250,000 every two weeks. All of that was owed before one bag of medicine went out the door.

The books said the business was growing twenty percent a year. The patient list, called the census, looked like it was growing even faster.

The diligence was real. Six months of it. Real advisors, real reports, real questions. Neil has a line about diligence that I think about all the time. It is like a seven-layer dip, he says. You dig until nothing smells. Then you stop. You never know if the bad layer is one layer below where you stopped.

Then, during those six months, something happened. Slow down for this part. The company’s best salesman, who carried two million dollars of the revenue, left. One man. A tenth of the business, walking out the door while the buyers were still counting it.

Was it disclosed? Neil’s words are careful, and mine will be too: it was not clearly disclosed. I once asked him, straight out, whether the seller hid it. He said, “I’m not going to talk about that.” The salesman left during diligence. The deal closed anyway. That is all I can tell you.

They closed in the winter. Neil remembers what he felt that day: “I thought all my dreams had come true.”

The Cracks

The dreams lasted about a month.

Neil walked in as owner and watched the patient count fall. Costs rose. Cash drained. The bank account went from about a million dollars to under a hundred thousand within his first two months.

The old staff stayed calm about it. This is normal for winter, they said. The owner just put money in this time of year.

Stop on that sentence. The owner just put money in. That is not a season. That is a business that eats cash, and a seller who had been feeding it quietly.

The whole model ran on overnight shipping. When a shipment got missed, someone had to drive the medicine out that night. To save overtime, the someone was Neil. The new owner of a twenty-million-dollar company, driving IV bags across Georgia in the dark, getting home at six in the morning.

While Neil drove, Chris dug. The company’s books tracked when cash moved, not when money was truly earned. Chris rebuilt them the right way in three months, a job that was planned to take a year. Bills got stretched to thirty days. Collections got chased hard.

Then came the first discovery. The census, that growing patient list, was full of ghosts. The same patient, counted more than once. The company had no patient ID numbers, nothing to match records against. When they finally scrubbed the list, about forty percent of it was duplicates. The growth was double-counting. The truth was that the business had been shrinking about ten percent a year. They had paid a growth price for a shrinking company.

Could diligence have caught it? Neil still asks it both ways. He could have caught it, he says. But should he have caught it? With no ID field, there was almost nothing to check the list against. Maybe the bad layer of the dip was one layer down. Maybe it always is.

The second discovery was where the profit lived. Three quarters of the revenue came from antibiotics, and antibiotics earned almost nothing. Break-even in a good month, swinging both ways in a bad one. One specialty line was different. It was only a quarter of the revenue, about five million dollars. But it threw off about two million dollars of profit, most of what the company truly earned. And it was the steady part. Patients on that therapy stay two to five years. It was the piece you could count on.

Neil described the company as a stool with two legs. One leg was big and wobbly. One leg was small and solid. There was no third leg.

And here is the part he admits without flinching. He was a sales expert with, in his own words, very little healthcare experience. In his old world, you set your price, fought for the deal, and the market answered. In this world, the price of that solid little leg was set somewhere else, off a published list, by people he would never meet. He knew that fact the way you know a country you have never visited. He did not yet feel it.

The Collapse

First, the comeback. Because there was one, it was real, and Neil earned it.

April, four months in: the first break-even month. Summer: the bank got nervous, waivers got signed, and it pushed the investors to put in more cash. The investors said no. Neil will tell you today that they were right. Fall: profit reached about $300,000 a month. That was the level in the plan. That was the number they had bought.

Sit with what that means. In nine months, this team absorbed a gutted sales book, a fake growth story, and a cash crisis, and clawed the company back to the exact plan they underwrote. Most buyers in this book never saw their plan again. Neil caught his. Thanksgiving came. The Christmas party came. He called it “a very sweet moment in time.”

Then he gave me the second half of that sentence: “that didn’t last very long.”

The bulletin landed in January. You have already read that morning. Ninety percent off the price of the therapy that carried most of their profit. About two million dollars a year, deleted by a list. The patients did not leave. The nurses did not leave. The work did not change. Only the pay changed, all at once, all the way down.

There was no one to fight. That is the part that breaks the usual playbook. No seller to sue. No rival to outsell. A committee somewhere had moved a number. Neil later called that cut the anvil that broke the camel’s back. Then he added the sentence that should scare you: “We just didn’t know it yet.”

They fought anyway. Fast and ugly first: about half the team was laid off within weeks. He is honest about that too. He thinks he should have cut deeper. The bank moved the loan to interest-only. No new investor money came. Under the strain, key people walked, including the head of collections.

Then the long fight. The stool needed a third leg, so they built one. A new specialty therapy line, started from zero, with no budget, sold on shoe leather. In about eighteen months it grew from nothing to seven million dollars a year. Do not rush past that. A wounded company built a seven-million-dollar business inside itself while it bled. As pure execution, it may be the best work in this book.

It was not enough. The new line kept only about twenty cents of margin on each drug dollar. Thin pay for heavy work. Revenue climbed back to twenty million, but profit whipsawed, up a hundred thousand one month, down two hundred the next. Neil calls those eighteen months what they were: running on fumes.

Then the fumes ran out. Vendors were waiting ninety days for their money. Neil stopped counting months of runway and started counting payrolls.

Here is where the story becomes the reason this chapter exists.

The bank and the investors had agreed to a rescue. About two million dollars of new money, approved, ready to wire. All Neil had to do was take it.

Instead he sat down with the model one last time and ran the business as it really was. The test came back simple and cruel. If drug margin slipped one percent, the model broke. One percent. And that slip was not some far-off risk. It was the weather in his industry, a slow erosion grinding on every line they sold, all the time.

So he called his own board, the people holding the wire, and told them he did not think their money was safe. Put this in, he said, and I think it could be gone within six months.

On that call, they decided to shut it down. Neil talked his investors out of rescuing him.

Within three days he was out. Most of the staff left the day the news broke. The bank asked for a plan to protect its interests, and Neil and Chris wrote it themselves. Neil’s words: “I wrote my own death plan.”

They wound it down with integrity. Healthcare has hard rules about walking away from patients, and the team beat those rules. Every patient was moved to a new pharmacy with medicine in hand. Neil says the staff did an amazing job, and he helped his people land new jobs where he could. A small crew stayed on to collect what was owed and hand it to the bank. No midnight filing. No vanished CEO. The company died the way Neil had run it: on the level.

The Cost

Count what three years cost him.

He never took a raise or a bonus as CEO. Not once. There was never cash to take. His savings drained to almost nothing. The house survived, and only because of one rule he did not write. His wife’s red line, no personal guarantee, drawn years before the search began, was the wall that held. He told me her fears had been “very palpable and very realistic.” That is a husband saying she was right.

The other costs do not fit in a ledger. His brother told him he had been a shell of his normal self at home for three years. Failure like this, Neil says, feels like it defines you the moment it lands. His therapy was not a program. It was smoke drifting off a barbecue pit, sawdust in the garage, and a guitar he had not touched in years.

Through all of it, he kept the only rules he claims: “I have two rules, which is don’t go to jail and sleep at night. That’s it.” He kept both.

And then the strangest entry in the whole ledger: the honesty paid. The investors whose two million dollars he refused did not scatter. They became his referral network. Within two weeks of the shutdown he had four signed consulting contracts and was earning more than he ever had as CEO. The market for people who tell you the truth on the worst day is small, and it pays well.

Would he do it again? “I don’t know,” he told me. Then the real answer: still married, and his kids love him. Slam dunk.

The Lesson

Be careful which lesson you take from this one, because the obvious lesson is wrong.

The obvious lesson is about diligence. The salesman who walked with two million of revenue. The census full of ghosts. Miss less, check more, dig one layer deeper into the dip. Fine. Dig.

But read the record. Neil survived every one of those misses. Nine months after walking into a shrinking, bleeding company, he had profit back to the exact plan. The diligence misses did not kill this company. Operationally, Neil won.

He lost anyway, because someone else set his prices.

Hold two facts side by side. Fact one: the company carried the most debt a bank would give, twelve million dollars against a little over three million of profit. Fact two: the price of the product earning most of that profit was set by strangers, off a list, changeable overnight, with no appeal. Either fact alone is survivable. Together they tie your survival to a list a stranger can rewrite. Neil’s model broke on a one percent slip in margin. The strangers took ninety.

So make pricing power diligence item number one. Before the accountants, before the lawyers, ask:

• Who sets the price of what this company sells? If the answer is not “the company does,” slow down.
• Can someone change that price without asking you? How fast, and how far? Neil’s answer turned out to be overnight, and ninety percent.
• Now look at your debt. Every borrowed dollar is a bet that margins hold. Take maximum debt into a business where someone else sets the price, and understand what you have done. You have handed a stranger the kill switch to your company. They will not fire it out of anger, the way Ray Hutchins did. They will fire it without ever learning your name.

From month six on, Neil and Chris had a running joke: we should have bought a landscaping company. A boring business. Neil aimed that one at me, knowing my own history with crews and mowers, and he waited for the laugh. I did not laugh. Lawns have no price list but your own.

One more thing before we move on. Neil’s killer was a committee he never met, a thousand miles away, and it never knew it killed anyone. The next buyer knew his killer’s face, his coffee order, and his kids’ names. The man had a desk down the hall.